Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
This study will test the ability of an immune modulator, anti-OX40 (MEDI6469) to alter the immune cell environment within colorectal cancer metastases. The drug will be administered to patients before surgical treatment.
创建时间：
2016-03-15
